BNET Industries

Digene Corp.

is in the Pharma Industry

Last Fiscal Year Sales:$152.8M
  • Private
  • US
Dow Jones Description

Digene's favorite letters are DNA and RNA. Founded in 1987 and headquartered in Gaithersburg, MD, Digene Corporation develops and markets generic tests that screen women for diseases, such as cancers and sexually transmitted diseases. The company has developed tests for diseases such as hepatitis B, Chlamydia, and cytomegalovirus. It also sells equipment and accessories used to perform these tests. The company generates annual revenue of about $115 million and employs about 400 people. In April 2006, the company and molecular diagnostic company, Asuragen Inc., entered into an agreement for the production and marketing of Asuragen's cystic fibrosis screening products.

Chairman & CEO
Evan Jones
Number of Employees 490
Contact Information

1201 Clopper Rd

Gaithersburg, Maryland 20878-4000

www.digene.com

(301) 944-7000

NAICS Code In-Vitro Diagnostic Substance Manufacturing: 325413

News & Analysis

digene corp. - All News and Analysis

  • Qiagen acquistion of Gaithersburg-based Digene Corp. advances

    - 2007-07-18

    Qiagen NV's acquisition of Digene Corp., a Gaithersburg-based maker of gene-based medical tests, has cleared an antitrust waiting period, the companies said Tuesday. Netherlands-based Qiagen, a diagnostic products maker, agreed to purchase Digene last month in a cash-and-stock deal worth approximately $1.6 billion. The expiration of the antitrust waiting period...

    Tags: Digene Corp., QIAGEN N.V.

  • Qiagen to acquire Digene

    - 2007-07-01

    M&AQiagen NV The Netherlands and Digene Corp US have signed a definitive agreement to combine the two companies. The boards of directors of both companies unanimously approved the transaction in which Qiagen is to acquire 100% of Digene's stock for a combination of cash and Qiagen common stock. It is...

    Tags: Digene Corp., QIAGEN N.V.

  • Molecular diagnostics

    - 2007-06-11

    Dutch diagnostics maker Qiagen has agreed to buy US firm Digene Corp for about $1.6bn in cash (55%) and stock (45%), in a deal that is expected to make Qiagen a market and technology leader in molecular diagnostics. Digene's primary product is a screen for the 13 high-risk types of...

    Tags: Digene Corp., Molecular Inc., QIAGEN N.V.

  • Qiagen NV to Buy Digene Corp.

    - 2007-06-05

    M2 PRESSWIRE-5 June 2007-HEADLINES: Qiagen NV to Buy Digene Corp.C1994-2007 M2 COMMUNICATIONS LTD RDATE:05062007 InvestorIM has been created as a tool for the average investor. The idea is simple, a website where the world can communicate. Do you have a stock...

    Tags: Digene Corp., QIAGEN N.V.

  • Digene Corp Bought By Qiagen.

    - 2007-06-05

    M2 PRESSWIRE-5 June 2007-HEADLINES: Digene Corp Bought By QiagenC1994-2007 M2 COMMUNICATIONS LTD RDATE:05062007 InvestorIM has been created as a tool for the average investor. The idea is simple, a website where the world can communicate. Do you have a stock related...

    Tags: Digene Corp., QIAGEN N.V.

  • Market Commentary on Qiagen NV.

    - 2007-06-04

    M2 PRESSWIRE-4 June 2007-Biotech News: Market Commentary on Qiagen NVC1994-2007 M2 COMMUNICATIONS LTD RDATE:04062007 QIAGEN let the "gene-ie" out of the bottle. The company makes the tools researchers need to extract and purify nucleic acids (DNA/RNA), making them easier for researchers...

    Tags: Digene Corp., QIAGEN N.V.

  • QIAGEN and Digene Announce Merger.

    - 2007-06-04

    M2 PRESSWIRE-4 June 2007-Making The Watchlist: QIAGEN and Digene Announce MergerC1994-2007 M2 COMMUNICATIONS LTD RDATE:04062007 Market Gainer is quickly emerging as the one stop shop for international small-cap investors looking to stay a step ahead of the markets. Activity on the...

    Tags: Digene, Digene Corp., QIAGEN N.V.

  • Digene and QIAGEN Announce Definitive Merger.

    - 2007-06-04

    M2 PRESSWIRE-4 June 2007-EIExplorationInvestor: Digene and QIAGEN Announce Definitive MergerC1994-2007 M2 COMMUNICATIONS LTD RDATE:04062007 Exploration Investor strives to provide you with outstanding market results. We will be your number one resource for all your small and large cap needs. While working...

    Tags: Digene Corp., QIAGEN N.V.

  • Digene Corp is Added to the Bellwether Watch list.

    - 2007-06-04

    M2 PRESSWIRE-4 June 2007-Biotech News: Digene Corp is Added to the Bellwether Watch listC1994-2007 M2 COMMUNICATIONS LTD RDATE:04062007 Digene Corp (NASDAQ:DIGE) is Added to the Bellwether Watch list Digene Corporation engages in the development, manufacture, and marketing of its...

    Tags: Digene Corp., QIAGEN N.V.

  • Digene Corp. of Gaithersburg reports strong sales

    - 2007-05-10

    Digene Corp., of Gaithersburg, which makes gene-based diagnostic tests, said its fiscal third-quarter profit surged on strong sales of its human papillomavirus test in the United States. For the quarter ended March 31, earnings were $5.3 million, or 21 cents per share, up from $1.1 million, or 5 cents per...

    Tags: Digene Corp., sales

Decision Makers

Name (plus bio) Position
Charles M. Fleischman President, CFO & COO
Attila T. Lorincz Senior Vice President
Belinda O. Patrick Senior Vice President, Manufacturing Operations
C. Douglas White Senior Vice President, Sales and Marketing, Americas and Asia Pacific
Joseph P. Slattery Senior Vice President, Finance
Robert Mcg Lilley Senior Vice President, Global Sales, Marketing
Vincent J. Napoleon General Counsel, Senior Vice President & Secretary
Allison Cullen Vice President, Product Development
Douglas White Vice President, North American Marketing, Sales
Larry Wellman Vice President, HR
Linda Alexander Vice President, Women's Health
Mark Vecchio Vice President, Clinical Affairs
Pamela Rasmussen Vice President, Corp Communications
Steve Rambo Vice President, Finance
Susan M. Keese Vice President, Marketing
William J. Payne Vice President, Automation & Engineering
Robert McG General Manager, Digene Europe
Renee Howell Director, Product Development
Donna Marie
Vincent J Napolean

Board of Directors

Name (plus bio) Position
Evan Jones Chairman & CEO
Cynthia L. Sullivan Board of Directors
Frank J. Ryan Board of Directors
John H. Landon Board of Directors
John J. Whitehead Board of Directors
Joseph M. Migliara Board of Directors
Kenneth R. Weisshaar Board of Directors

Organization Position Status
Digene Corporation Chairman & CEO Current
Opgen, Inc. Board Member Current
CAS Medical Systems, Inc. Board Member Current
CAS Medical Systems, Inc. Managing Member Current
PerkinElmer, Inc. Former
University of Colorado B.A. in Biochemistry Former

Organization Position Status
Inhealth President Current
Digene Corporation President, CFO & COO Current
Inhealth Board of Directors Current
S.Com, Inc. Executive Vice President Former
Harvard University A.B. in History Former

Organization Position Status
Digene Corporation Senior Vice President Current
Trinity College Ph.D. in Genetics Former

Organization Position Status
Digene Corporation Senior Vice President, Manufacturing Operations Current

Organization Position Status
Dxma Senior Vice President, Mdx Sales and Marketing Americas, Qiagen Current
Digene Corporation Senior Vice President, Sales and Marketing, Americas and Asia Pacific Current
Dxma Board of Directors Current
Roche Molecular Systems, Inc. Senior Vice President of Global Marketing Former
Bayer Corporation Vice President of Sales and Marketing Former
Abbott Diagnostics Former
Chiron Former
Washington College B.A. In Political Science Former

Organization Position Status
Digene Corporation Senior Vice President, Finance Current
Cvrx Inc Board of Directors Current
Ernst & Young Former
KPMG International Former
Bentley College B.S. in accounting Former

Organization Position Status
Digene Corporation Senior Vice President, Global Sales, Marketing Current
Yale University B.A. in Political Science Former

Organization Position Status
Digene Corporation General Counsel, Senior Vice President & Secretary Current
PricewaterhouseCoopers Managing Director Former
University of Pittsburgh J.D. Former
Georgetown University B.S. Former

Organization Position Status
Digene Corporation Vice President, Product Development Current

Organization Position Status
Digene Corporation Vice President, North American Marketing, Sales Current

Organization Position Status
Digene Corporation Vice President, HR Current

Organization Position Status
Digene Corporation Vice President, Women's Health Current

Organization Position Status
Digene Corporation Vice President, Clinical Affairs Current

Organization Position Status
Digene Corporation Vice President, Corp Communications Current

Organization Position Status
Digene Corporation Vice President, Finance Current

Organization Position Status
Digene Corporation Vice President, Marketing Current

Organization Position Status
Digene Corporation Vice President, Automation & Engineering Current

Organization Position Status
Digene Corporation General Manager, Digene Europe Current
Digene Corporation architect Current
Yale University B.A. in political science Former

Organization Position Status
Digene Corporation Director, Product Development Current

Organization Position Status
Digene Corporation Current
PerkinElmer, Inc. Senior Director for Business Development Former

Organization Position Status
Digene Corporation Current
PricewaterhouseCoopers Managing Director Former
GE Aerospace Former
Office of the Solicitor Former
University of Pittsburgh J.D. Former
Georgetown University B.S. Former

Cynthia Sullivan , 51 , currently serves as President and Chief Executive Officer of Immunomedics (NasdaqGM: IMMU), a biopharmaceutical company focused on the development of products for cancer, autoimmune, and other serious diseases. She has been employed by Immunomedics since 1985 and has held various positions, including Executive Vice President, Chief Operating Officer, and President. Prior to joining Immunomedics, Ms. Sullivan was employed by Ortho Diagnostic Systems, Inc., a subsidiary of Johnson & Johnson. She earned a BS from Merrimack College, North Andover, Massachusetts, followed by a year of clinical internship with the school of Medical Technology at Muhlenberg Hospital, Plainfield, New Jersey, resulting in a M.T. (ASCP) certification. She completed an MS degree from Fairleigh Dickinson University where she also received her MBA. Ms. Sullivan was appointed as chairperson of the Company's audit committee.

Organization Position Status
Immunomedics, Inc. Chief Executive Officer Current
IBC Pharmaceuticals, Inc. President Current
Immunomedics, Inc. President Current
Urigen Pharmaceuticals, Inc. Board of Directors Current
Digene Corporation Board of Directors Current
Immunomedics, Inc. Board of Directors Current
Immunomedics, Inc. Chief Operating Officer Former
Immunomedics, Inc. Executive Vice President Former
Immunomedics, Inc. Executive Director, Operations Former
Fairleigh Dickinson University MS Degree Former
Merrimack College BS Former
Digene Corporation member Former

Mr. Ryan has been a director since November 2002. Mr. Ryan was a director of Digene Corporation from June 2005 until its acquisition by Qiagen N.V. in July 2007. Mr. Ryan’s career includes a 38-year tenure with Johnson & Johnson. Mr. Ryan retired in 2001 as Johnson & Johnson’s company group chairman with responsibility for worldwide Ethicon franchises and Johnson & Johnson Canada. In addition, Mr. Ryan was a member of the Medical Devices and Diagnostics Operating Group and Leader for the Group in Process Excellence (Six Sigma) and IT. Throughout his years at Johnson & Johnson, Mr. Ryan held positions of increasing responsibility, including worldwide president of Chicopee, president of Johnson and Johnson Hospital Services Co. and president of Ethicon, Inc. Mr. Ryan received a B.S. degree in Mechanical Engineering from the Illinois Institute of Technology in 1965 and an M.B.A. from the University of Chicago Graduate School of Business in 1969.

Organization Position Status
PDI, Inc. Board of Directors Current
Digene Corporation Board of Directors Current
Ethicon, Inc. President Former
Johnson & Johnson President Former
Johnson & Johnson Ethicon Former
Johnson & Johnson Chairman Former
University of Chicago M.B.A. Former
Illinois Institute of Technology B.S. degree in mechanical engineering Former

Organization Position Status
Digene Corporation Board of Directors Current

Organization Position Status
Digene Corporation Board of Directors Current
Williams College B.S. in Biology and Chemistry Former

Organization Position Status
Digene Corporation Board of Directors Current
Adfluence, Inc. Board of Directors Current
The Interpublic Group of Companies, Inc. Former
Fairleigh Dickinson University M.B.A. Former

Mr. Weisshaar became a non-executive Director of Orthofix International N.V. in December 2004. Most recently, Mr. Weisshaar has served as Chief Operating Officer and strategy advisor for Sensatex, Inc. Also, Mr. Weisshaar spent 12 years as a corporate officer at Becton Dickson, a medical device company, where at different times he was responsible for global businesses in medical devices and diagnostic products and served as Chief Financial Officer and Vice President, Strategic Planning. Mr. Weisshaar earned a bachelor of science degree from MIT and an MBA from Harvard University. He currently also serves on the board of Digene Corporation.

Organization Position Status
Digene Corporation Board of Directors Current
Orthofix International N.V. Board of Directors Current
Precision Therapeutics, Inc. Director Current
Orthofix Inc. Director Current
Sensatex, Inc Chief Operaing Officier and Strategy Advisor Former
Orthofix International N.V. Non-Executive Director Former
Sensatex, Inc Strategy Advisor Former
Becton, Dickinson & Company Former
Harvard University MBA Former
Harvard Business School M.B.A. Former
Harvard University Bachelor of Science Degree Former

Executive News

  • UCB and Immunomedics Announce Positive Results for Epratuzumab Phase IIb Study in...

    Reuters - 8/27/09 - View Story

  • Immunomedics Announces FDA Allowance of Investigational New Drug Application for...

    Reuters - 8/14/09 - View Story

advertisement
IndustryTop Rated

Brought to you by CBS MoneyWatch.com

advertisement
Click Here
Presented by the Premiere Rewards Gold Card from American Express